Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 20, 2025 08:29 ET | Source: NovelStem International Corp.

NovelStem Announces Material Developments and Strategic Repositioning of the Company

$NSTM: NovelStem Announces Material Developments and Strategic Repositioning of the Company.
December 01, 2020 08:33 ET | Source: NovelStem International Corp.

NovelStem Increases NewStem Ownership to 33% as NewStem Prepares for First-Half 2021 FDA Filing for Approval of its Stem-Cell Based Anti-Cancer Drug Resistance Diagnostic; NovelStem Initiates Process to Become Publicly-Reporting with S.E.C. and to Up-List its Shares

BOCA RATON, Fla. and JERUSALEM, Dec. 01, 2020 (GLOBE NEWSWIRE) -- NovelStem International Corp. (OTC Pink: NSTM), a biotechnology company focused on its stem cell-based technology platform,...
April 21, 2020 08:30 ET | Source: NovelStem International Corp.

NovelStem Announces New Research Collaborations for Stem-Cell Technology Platform in Cancer Immunotherapy and COVID-19 Resistance; Reports Progress Identifying Genetic Resistance to Additional Anti-Cancer Treatments

Screening of resistance diagnostics completed for twelve standard-of-care cancer treatments representing a significant portion of cancer treatment protocols. COVID-19 research collaboration initiated...
December 16, 2019 08:07 ET | Source: NovelStem International Corp.

NovelStem Increases NewStem Ownership to 27.3% Following Achievement of Development Milestones for Stem-Cell-Based Cancer Treatments Resistance Diagnostic

BOCA RATON, Fla. and JERUSALEM, Israel, Dec. 16, 2019 (GLOBE NEWSWIRE) -- NovelStem International Corp. (OTC Pink: NSTM), a biotechnology company focused on stem-cell-based diagnostic technology to...
May 08, 2019 08:03 ET | Source: NovelStem International Corp.

NovelStem Provides Shareholder Update

BOCA RATON, Fla., May 08, 2019 (GLOBE NEWSWIRE) -- NovelStem International Corp. (OTC Pink: NSTM) is focused on the substantial commercial potential of stem-cell-based diagnostic technology to aid...
September 25, 2018 16:02 ET | Source: NovelStem International Corp.

Hollywood Media Changes Name and Stock Symbol to NovelStem International Corp. and “NSTM” to Reflect Focus on Stem Cell-Based Diagnostics to Better Select Cancer Chemotherapies

BOCA RATON, Fla. and JERUSALEM, Israel, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Hollywood Media Corp. (OTC Pink: HOLL) announced today it has changed its corporate name to NovelStem International Corp....
July 16, 2018 01:00 ET | Source: Hollywood Media Corp.

Hollywood Media Completes Transformational Investment in NewStem, Israel-Based Developer of Haploid Stem Cell-Based Diagnostics to Predict Chemotherapy Resistance

Raises $1.925 Million to Support a $2 Million Initial Investment in NewStem Ltd.Appoints New Board of Directors Led by Jan Loeb as ChairmanForms New Leadership Team with Deep Healthcare ExpertisePlans...
March 15, 2018 15:03 ET | Source: Hollywood Media Corp.

Hollywood Media Advances Pay Date to March 29 for $0.45 per Share Special Distribution

BOCA RATON, Fla., March 15, 2018 (GLOBE NEWSWIRE) -- Hollywood Media Corp. (OTC Pink:HOLL) today provided updated timing for the record date, pay date and ex-dividend date for its previously...
March 01, 2018 09:37 ET | Source: Hollywood Media Corp.

Hollywood Media Provides Update on Mechanics of Special One-Time Distribution of $0.45 Per Share

BOCA RATON, Fla., March 01, 2018 (GLOBE NEWSWIRE) -- Hollywood Media Corp. (OTC Pink:HOLL) today provided an update to clarify the treatment of the special $0.45 per share cash distribution to...
January 16, 2018 16:01 ET | Source: Hollywood Media Corp.

Hollywood Media Corp. to Distribute $0.45 per Share to Shareholders and Focus on Realizing Value of Remaining Assets, Including Netco Partners JV, and Approves 1 Million Share Repurchase Plan

BOCA RATON, Fla., Jan. 16, 2018 (GLOBE NEWSWIRE) -- Hollywood Media Corp. (OTC Pink:HOLL) today announced a $0.45 per share cash distribution to its shareholders following the recently completed...